AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
LoanDepot's 15-Minute Chart Triggers MACD Death Cross, KDJ Death Cross Alert
ByAinvest
Wednesday, Sep 24, 2025 9:51 am ET1min read
Based on the 15-minute chart for loanDepot, the MACD Death Cross and KDJ Death Cross indicators triggered on September 24, 2025, at 09:45. This suggests that the stock price has the potential to continue declining, with a shift in momentum towards the downside and a possible further decrease in value.
loanDepot, Inc. (NYSE: LDI) experienced unusual options trading activity on Monday, September 22, 2025, with stock investors purchasing 20,699 call options, an 82% increase compared to the typical daily volume of 11,345 call options [1]. The stock traded down $0.33 during mid-day trading, hitting $3.40, with a trading volume of 7,016,220 shares, compared to its average volume of 2,992,603. The company has a market cap of $1.12 billion, a P/E ratio of -10.26, and a beta of 3.38 [1].Technical Indicators Signal Further Downward Pressure
On September 24, 2025, at 09:45, the 15-minute chart for loanDepot triggered both the MACD Death Cross and KDJ Death Cross indicators. These technical indicators suggest a shift in momentum towards the downside, potentially leading to further declines in the stock price [2].
Institutional and Insider Activity
Institutional investors and hedge funds have been active in loanDepot's shares. Wilshire Advisors LLC, Invesco Ltd., Los Angeles Capital Management LLC, Vanguard Personalized Indexing Management LLC, and Capstone Financial Advisors Inc. have all increased their positions in the company [1]. Additionally, insiders have sold 14,470,160 shares of company stock valued at $40,335,701 in the last three months [1].
Analyst Ratings and Target Prices
Several analysts have commented on loanDepot's shares. UBS Group raised their price objective on shares of loanDepot from $1.40 to $1.90, giving the stock a "neutral" rating. Wall Street Zen lowered loanDepot from a "hold" rating to a "sell" rating. BTIG Research reaffirmed a "neutral" rating on shares of loanDepot [1]. The stock currently has a consensus rating of "Reduce" and an average target price of $2.30 [1].
About loanDepot
loanDepot, Inc. engages in originating, financing, selling, and servicing residential mortgage loans in the United States. The company offers conventional agency-conforming and prime jumbo, federal assistance residential mortgage, and home equity loans. It also provides settlement services, real estate services, and insurance services [1].
References
[1] https://www.marketbeat.com/instant-alerts/loandepot-target-of-unusually-large-options-trading-nyseldi-2025-09-22/
[2] https://www.tradingview.com/news/reuters.com,2025:newsml_L6N3V50TE:0-jefferies-financial-amer-sports/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet